Your Messages Inbox
Your Article Summary
See Latest ArticlesInnovative IV Catheter Receives FDA Clearance and Secures Funding from Washington Area Venture Capital Firm
Corporate News Releases - The Healthcare Sales & Marketing Network, 12/03/08
The Zitelman Group announced it has led a $600,000 Series B Preferred equity round for Israel-based medical device firm, Flexicath, Ltd. Flexicath received a 510(k) clearance from FDA in October, allowing it to place its FirmGrip sterile catheter intravenous (IV) system in the U.S market. The funding will be used to ramp-up U.S. and international sales and marketing for the FirmGrip catheter.
Today in Drug/Product Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
Telmisartan/amlodipine: approved for high blood pressure
Formulary , 12/16/09
Eslicarbazepine: A novel antiepileptic agent designed for improved efficacy and safety
Formulary , 12/16/09
Human genome sciences announces submission of marketing authorization application to emea for joulferon
Human Genome Sciences, 12/16/09
Article Search
Sponsor